Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from AACR

U.S. Cancer Death Rate Fell 35% Since 1991, Led by Lung Cancer, as Diagnoses Rise in Younger Adults

The AACR says the U.S. cancer death rate fell 35% from 1991 to 2024, averting more than 4.8 million deaths, while cancer keeps rising in younger adults.

Medical Daily · Sep 24

Harrowing US Health Study Discovers Black and Native American Communities Suffer Disproportionately High Cancer Death Tolls

A US cancer report reveals persistent racial and economic disparities in cancer mortality, despite a 35% drop in overall death rates since 1991. Funding cuts threaten further progress.

International Business Times UK · Jun 24

Accelerated Aging Raises Cancer Risk In Young Adults: Study

The researchers suggest that their discoveries open the door for future interventions to slow biological aging that could be a new avenue for cancer prevention.

Medical Daily · Apr 9, 2024

From analysis to the latest developments in health,
read the most diverse news in one place.

Phio Pharma's New Preclinical Data Shows PH-894 Enhances Activity of Cancer CAR-T Cells

Phio Pharmaceuticals Corp (NASDAQ:PHIO) presented new preclinical data showing that silencing BRD4 with PH-894 can improve the quality and potency of HER2-targeted CAR-T cells in a CAR-T expansion model. These new data will be presented at the American Society of Gene & Cell Therapy (ASGCT) 25th Annual Meeting. Related: Phio Pharma Shares Shine After…

Benzinga · May 16, 2022

Iovance Receives FDA Allowance For IOV-4001 Study In Two Advanced Cancers

The FDA has signed off Iovance Biotherapeutics Inc's (NASDAQ:IOVA) Investigational New Drug Application (IND) first genetically modified TIL therapy, IOV-4001, for unresectable or metastatic melanoma and stage III or IV non-small-cell lung cancer (NSCLC). IOV-4001 leverages the gene-editing TALEN technology licensed from Cellectis SA (NASDAQ:CLLS). A clinical study of IOV-4001 in patients with metastatic melanoma…

Benzinga · Mar 16, 2022

Coverage From

Organisations

the American Cancer Society

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

United States

424,785 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.